tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Summit Therapeutics up 1% after report on AstraZeneca partnership talks
PremiumThe FlySummit Therapeutics up 1% after report on AstraZeneca partnership talks
1M ago
AstraZeneca discussing $15B partnership with Summit Therapeutics, Bloomberg says
Premium
The Fly
AstraZeneca discussing $15B partnership with Summit Therapeutics, Bloomberg says
1M ago
Summit Therapeutics trading resumes
Premium
The Fly
Summit Therapeutics trading resumes
1M ago
Revolution Medicines, Summit Therapeutics enter clinical collaboration
PremiumThe FlyRevolution Medicines, Summit Therapeutics enter clinical collaboration
1M ago
Revolution Medicines, Summit Therapeutics team to evaluate RAS inhibitors
Premium
The Fly
Revolution Medicines, Summit Therapeutics team to evaluate RAS inhibitors
1M ago
Summit Therapeutics’ Promising Clinical Trials and Market Potential Drive Buy Rating
Premium
Ratings
Summit Therapeutics’ Promising Clinical Trials and Market Potential Drive Buy Rating
1M ago
Summit Therapeutics initiated with an Underperform at Leerink
PremiumThe FlySummit Therapeutics initiated with an Underperform at Leerink
2M ago
Optimistic Outlook for Summit Therapeutics: Buy Rating Affirmed Despite OS Miss in HARMONi Trial
Premium
Ratings
Optimistic Outlook for Summit Therapeutics: Buy Rating Affirmed Despite OS Miss in HARMONi Trial
2M ago
Bristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist
Premium
The Fly
Bristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100